Health and Healthcare

Big Holder Chasing STAAR Surgical (STAA)

money-stack-imageSTAAR Surgical Company (NASDAQ: STAA) has been on a roaring run of late.  In mid-May this stock was under $1.00.  After news of the company getting a nod for its Epiphany cataract lens insertion device, its stock has risen almost 100% and traded north of $2.00 before coming back to $1.94 today.  And then came a capital raise. What is interesting is that a large holder added a large amount to the ownership in that offering.

The company’s direct registered offering was just completed this week and was over 4.255 million shares at $1.88 per share.  Via an SEC filing, it turns out that Broadwood Partners LP (or tied to Neal Bradsher) purchased 1,159,362 of those shares.  This now gives the fund a total ownership of 6,028,638 shares.

STAAR is using the capital raised to fund a deposit with the court to secure a stay of enforcement of the judgment pending its appeal in the Parallax Medical Systems, Inc. litigation. The current temporary stay in the case expires on June 22, 2009.

We have Broadwood as being the largest holder by far, and this will now give it close to 20% of the total company if the last data on the total share count is accurate.

Jon C. Ogg
June 18, 2009

Credit Card Companies Are Doing Something Nuts

Credit card companies are at war. The biggest issuers are handing out free rewards and benefits to win the best customers.

It’s possible to find cards paying unlimited 1.5%, 2%, and even more today. That’s free money for qualified borrowers, and the type of thing that would be crazy to pass up. Those rewards can add up to thousands of dollars every year in free money, and include other benefits as well.

We’ve assembled some of the best credit cards for users today.  Don’t miss these offers because they won’t be this good forever.

Flywheel Publishing has partnered with CardRatings for our coverage of credit card products. Flywheel Publishing and CardRatings may receive a commission from card issuers.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.